In the News

Ron Garrow notes that the industry’s efforts to constantly bend the time and cost curve of drug development, while remaining committed to quality and patient safety, mesh with the mindset of Generation Z.

Krystina Fuge and Brian Ford discuss how resource forecasting, quality and training of staff, and innovation impact function service partnerships.

Anna Long says the decentralizing of trials is likely to appeal to a greater diversity of patients, especially younger generations that have grown up with technology and the flexibility and interactivity it affords.

PPD was named Best CRO Provider at the sixth-annual World ADC Awards, according to a news release.

Christopher Lester, Timothy Ramsey and Jonathon Salsbury discuss an oil-water extraction process that can be used to separate endotoxins from oily drug formulations.

Real-world evidence (RWE) – what is its true value in health technology assessment? This is a question continually faced by biotech and pharmaceutical companies.

PPD country experts discuss how local government changes are anticipated to cause a steady increase in clinical research across the region and expand its role in the global development of new therapeutic treatments.

BioPharm International spoke with Marybeth Reynoso, senior director, early development strategic operations at PPD about the direction the industry is taking regarding the outsourcing of early development operations to contract research organizations.

Randy Marchbanks of PPD discusses how CRO operations have evolved to accommodate changing industry needs.